Charnwood Molecular, a UK-based pre-clinical discovery CRO serving the global pharmaceutical and biotechnology market, has opened its new facilities at Charnwood Campus, Loughborough.   Charnwood Molecular has become the sole occupier of a three-story laboratory facility at Charnwood Campus which will house over 150 scientists. With the company’s recent acquisition of Aurelia Bioscience, it is now well prepared for the next phase of its development as a company focused on discovery and innovat...